Cargando…
ERK1/2 in immune signalling
Extracellular signal-related kinases 1 and 2 (ERK1/2) are the final components of the mitogen-activated protein kinase (MAPK) phosphorylation cascade, an integral module in a diverse array of signalling pathways for shaping cell behaviour and fate. More recently, studies have shown that ERK1/2 plays...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704528/ https://www.ncbi.nlm.nih.gov/pubmed/36281999 http://dx.doi.org/10.1042/BST20220271 |
_version_ | 1784840073975431168 |
---|---|
author | Lucas, Richard M. Luo, Lin Stow, Jennifer L. |
author_facet | Lucas, Richard M. Luo, Lin Stow, Jennifer L. |
author_sort | Lucas, Richard M. |
collection | PubMed |
description | Extracellular signal-related kinases 1 and 2 (ERK1/2) are the final components of the mitogen-activated protein kinase (MAPK) phosphorylation cascade, an integral module in a diverse array of signalling pathways for shaping cell behaviour and fate. More recently, studies have shown that ERK1/2 plays an essential role downstream of immune receptors to elicit inflammatory gene expression in response to infection and cell or tissue damage. Much of this work has studied ERK1/2 activation in Toll-like receptor (TLR) pathways, providing mechanistic insights into its recruitment, compartmentalisation and activation in cells of the innate immune system. In this review, we summarise the typical activation of ERK1/2 in growth factor receptor pathways before discussing its known roles in immune cell signalling with a focus downstream of TLRs. We examine emerging research uncovering evidence of dysfunctional ERK1/2 signalling in inflammatory diseases and discuss the potential therapeutic benefit of targeting ERK1/2 pathways in inflammation. |
format | Online Article Text |
id | pubmed-9704528 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Portland Press Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97045282022-12-06 ERK1/2 in immune signalling Lucas, Richard M. Luo, Lin Stow, Jennifer L. Biochem Soc Trans Review Articles Extracellular signal-related kinases 1 and 2 (ERK1/2) are the final components of the mitogen-activated protein kinase (MAPK) phosphorylation cascade, an integral module in a diverse array of signalling pathways for shaping cell behaviour and fate. More recently, studies have shown that ERK1/2 plays an essential role downstream of immune receptors to elicit inflammatory gene expression in response to infection and cell or tissue damage. Much of this work has studied ERK1/2 activation in Toll-like receptor (TLR) pathways, providing mechanistic insights into its recruitment, compartmentalisation and activation in cells of the innate immune system. In this review, we summarise the typical activation of ERK1/2 in growth factor receptor pathways before discussing its known roles in immune cell signalling with a focus downstream of TLRs. We examine emerging research uncovering evidence of dysfunctional ERK1/2 signalling in inflammatory diseases and discuss the potential therapeutic benefit of targeting ERK1/2 pathways in inflammation. Portland Press Ltd. 2022-10-31 2022-10-25 /pmc/articles/PMC9704528/ /pubmed/36281999 http://dx.doi.org/10.1042/BST20220271 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY) (https://creativecommons.org/licenses/by/4.0/) . Open access for this article was enabled by the participation of the University of Queensland in an all-inclusive Read & Publish agreement with Portland Press and the Biochemical Society under a transformative agreement with CAUL. |
spellingShingle | Review Articles Lucas, Richard M. Luo, Lin Stow, Jennifer L. ERK1/2 in immune signalling |
title | ERK1/2 in immune signalling |
title_full | ERK1/2 in immune signalling |
title_fullStr | ERK1/2 in immune signalling |
title_full_unstemmed | ERK1/2 in immune signalling |
title_short | ERK1/2 in immune signalling |
title_sort | erk1/2 in immune signalling |
topic | Review Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704528/ https://www.ncbi.nlm.nih.gov/pubmed/36281999 http://dx.doi.org/10.1042/BST20220271 |
work_keys_str_mv | AT lucasrichardm erk12inimmunesignalling AT luolin erk12inimmunesignalling AT stowjenniferl erk12inimmunesignalling |